| PROQR THERAPEUTICS EO-,04 |
| Niederlande |
| Gesundheit |
| NL0010872495 / A12B97 |
| 0PQ (Frankfurt) / PRQR (NASDAQ) |
| FRA:0PQ, ETR:0PQ, 0PQ:GR, NASDAQ:PRQR |
| - |
| https://www.proqr.com/ |
|
ProQR Therapeutics N.V. is a biotechnology company specializing in the development of transformative RNA-based therapies for genetic disorders. Founded in 2012 and based in the Netherlands, the compan..
>Volltext.. |
| 165.48 Mio. EUR |
| 72.66 Mio. EUR |
| 14.79 Mio. EUR |
| -40.64 Mio. EUR |
| -40.96 Mio. EUR |
| -0.4 EUR |
| 14.88 Mio. EUR |
| 108.99 Mio. EUR |
| -47.9 Mio. EUR |
| 3.23 |
| -16.51% |
| -72.17% |
| - |
| - |
| - |
| - |
| PROQR |
| 13.03.26 |
|
||||
|
||||
|